NervGen Pharma Corp.

Nervgen pharma corp. email format

Verified email-pattern data for Nervgen Pharma Corp. is currently limited. You can still use the company insights and contact sections below.
NervGen is a publicly traded (TSX-V: NGEN, OTCQX: NGENF) clinical stage biotech company dedicated to discovering and developing innovative treatments for nervous system damage, due to injury or disease. NervGen’s lead drug candidate, NVG-291, is a first of its kind experimental drug administered by injection under the skin. NVG-291 relieves the inhibitory effects of CSPGs and thus enables nervous system repair. In animal studies, this therapeutic approach promoted nervous system repair and enhanced recovery of functions such as walking, bladder control, vision, and memory. NVG-291 entered Phase 1 clinical trials in 2021. After completing our Phase 1 clinical trial, we plan to study the effectiveness and safety of NVG-291 initially in people with spinal cord injury, Alzheimer’s disease and multiple sclerosis.

Company Details

Employees
21
Founded
-
Address
2955 Virtual Way, 480,canada
Industry
Biotechnology Research
HQ
Vancouver, British Columbia
Looking for a particular NervGen Pharma Corp. employee's phone or email?

Nervgen Pharma Corp. Questions

Top NervGen Pharma Corp. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant